Interleukin-10 (IL-10) transcriptional regulation (IL-10 regulation)

Interleukin-10 (IL-10) transcriptional regulation is the complex biological process that controls the expression of the IL10 gene, which encodes a major anti-inflammatory cytokine (Saraiva & O'Garra, 2010, Nature Reviews Immunology). This regulation is primarily driven by the recruitment of transcription factors such as Signal Transducer and Activator of Transcription 3 (STAT3), Sp1, and c-Maf to the IL10 promoter and distal enhancers (Iyer & Cheng, 2012, Critical Reviews in Immunology). Epigenetic modifications, including histone acetylation and DNA methylation at the IL10 locus, also play a critical role in determining the accessibility of the gene to the transcriptional machinery (Gabryšová et al., 2014, Cytokine & Growth Factor Reviews). In clinical contexts, proper IL-10 regulation is vital for maintaining immune homeostasis and preventing excessive tissue damage during infection or inflammation. Dysregulation of this process is implicated in various diseases, where insufficient IL-10 leads to chronic inflammatory conditions like Crohn's disease, while excessive IL-10 can facilitate tumor growth by suppressing anti-tumor immunity. Pharmacological agents such as phosphodiesterase-4 (PDE4) inhibitors and certain corticosteroids are known to modulate IL-10 levels by influencing the signaling pathways that govern its transcription. Consequently, targeting the regulatory elements of IL-10 expression represents a significant therapeutic strategy for balancing immune responses in both autoimmune and oncological settings.

Other names

Interleukin-10 gene expression controlIL-10 promoter regulationRegulation of Interleukin-10 production

Modulation of transcription factor binding (e.g., STAT3, Sp1) and epigenetic modifications at the IL10 gene promoter to regulate cytokine synthesis.